Kao develops new test method for Parkinson's disease patients

 Kao has formed a research group with Juntendo University Graduate School of Medicine, Senior Associate Professor Shinji Saiki, Professor Nobutaka Hattori, and Preferred Networks (PFN). Discovered that it contains information.

Furthermore, it was clarified that a machine learning model using sebum RNA information could be a diagnostic method for Parkinson's disease.

These results showed the possibility of a new test method for Parkinson's disease using a biological component called sebum RNA, which is simple and can be collected without invasion (event that disturbs homeostasis in the living body), and the pathological condition. It is said that it is significant in that it leads to early diagnosis based on.

This result was published in the online version of the British scientific journal "Scientific Reports".

At an online press conference held on September 21, Takayoshi Inoue, the project leader of the Sebum RNA Project at the Kao Institute of Biological Sciences, commented on the significance of this research. Based on the discovery that it is contained in sebum, we have succeeded in constructing a technology to comprehensively analyze human RNA expression information in sebum. Sebum can be collected by anyone, anytime, anywhere. In other words, the biggest feature is that it is possible to collect biological components using only one oil-removing film. This time, it is very significant that it was suggested that sebum RNA information could monitor the disease state in the body. I think there is. "

Comments

Popular posts from this blog

L'Oréal forms research and technology alliance with Israeli climate tech company

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

L'Oreal Research & Innovation, Morishita Jintan Co., Ltd. and L'Oreal's first successful development of cutting-edge "active delivery capsules" made of useful ingredients for plant-derived cosmetics